Menu:
Calcium Channel Blocker
Blogs about Calcium Channel Blocker
- Hypertension Clinical Trial: Trial to Evaluate the Effect of ... »
The purpose of this study is to assess the effect of Tekturna (aliskiren), in combination with an ACE and calcium channel blocker in hypertensive patients diagn...
- Health Insight: Calcium Channel Blocker, Poisoning »
Calcium Channel Blocker, Poisoning Description Three Classes of Calcium Channel Blockers Phenylalkylamines (verapamil): o Vasodilation resulting in a decrease in blood pressure (BP) o Negative chronotropic and inotropic effects: ...
- Tekturna, Ambien Cr, Allopurinol, Lipitor, Labetalol Hydrochloride ... »
Date: Oct, 21, 2009 Patient demographics: 65 year(s) old Male who has HBP, Poor Quality Sleep, Gout, Cholesterol, Beta blockers overdose, Calcium Channel Blocker Hpb, Ace Inhibitor Hbp, Lasix.
- Amlodipine: Drug Whys »
Generic Name: Amlodipine (multiple manufacturers) Common Brand Name: Norvasc (Pfizer US) Popularity: 14th most commonly prescribed drug between 2002 2007 (US) Class: Calcium channel blocker.
- MPR »
The FDA has approved Azor (amlodipine/olmesartan medoxomil tablets, from Daiichi Sankyo), a combination product containing a calcium channel blocker and an angiotensin II receptor blocker, as firstline therapy in patients likely to ...
- What blood pressure target in hypertension, and what drug to try ... »
The review found that thiazides had the most robust evidence base, more so than ACEinhibitors or calcium channel blockers, and there was no evidence to support firstline use of angiotensin receptor blockers (known as A2RAs, ...
Selected News
Forest Laboratories Announces Resignation of Ivan Gergel, MD (The San Francisco Examiner)
NEW YORK, March 19 /PRNewswireFirstCall/ Forest Laboratories, Inc. (NYSE: FRX ) today announced that Ivan Gergel , MD, Senior Vice President Scientific Affairs and President of the Forest Research Institute has resigned his position and will leave the Company effective March 31, 2008 . Read more
Eisai Announces Vasolan(R) (Ischaemic Heart Disease Treatment) Received Approval for Atrial Fibrillation/Flutter and ... (JCN Newswire via Yahoo7 Finance)
Tokyo, Japan, Mar 4, 2008 (JCN Newswire) Eisai Co., Ltd. (TSE: 4523) announced today that Vasolan(R) Tablets 40mg (generic name: verapamil hydrochloride) received approval for the additional indications of the treatment of atrial fibrillation/flutter and paroxysmal supraventricular tachycardia. This approval makes Vasolan the first oral form of calcium channel blockers approved for the ... Read more
26 March 2008 (PharmiWeb)
Tokyo, Japan, Mar 4, 2008 (JCN Newswire) Eisai Co., Ltd. (TSE: 4523) announced today that Vasolan(R) Tablets 40mg (generic name: verapamil hydrochloride) received approval for the additional indications of the treatment of atrial fibrillation/flutter and paroxysmal supraventricular tachycardia. Read more
Related Calcium Channel Blocker Websites
- None yet